Sirona Biochem (TSXV:SBM) Change In Inventory : C$0.00 Mil (TTM As of Jan. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem Change In Inventory?

Sirona Biochem's change in inventory for the quarter that ended in Jan. 2024 was C$0.00 Mil. It means Sirona Biochem's inventory stayed the same from Oct. 2023 to Jan. 2024 .

Sirona Biochem's change in inventory for the fiscal year that ended in Oct. 2023 was C$0.00 Mil. It means Sirona Biochem's inventory stayed the same from Oct. 2022 to Oct. 2023 .

Sirona Biochem's Total Inventories for the quarter that ended in Jan. 2024 was C$0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sirona Biochem's Inventory-to-Revenue for the quarter that ended in Jan. 2024 was 0.00.

Sirona Biochem Change In Inventory Historical Data

The historical data trend for Sirona Biochem's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Change In Inventory Chart

Sirona Biochem Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Change In Inventory

Get a 7-Day Free Trial

Sirona Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Sirona Biochem Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Sirona Biochem (TSXV:SBM) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sirona Biochem's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sirona Biochem's Inventory Turnover for the quarter that ended in Jan. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sirona Biochem's Inventory to Revenue for the quarter that ended in Jan. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.002
	=	0.00

Sirona Biochem Change In Inventory Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirona Biochem (TSXV:SBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

SRBCF:USA ZSB:Germany

Address

C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3

Website

https://www.sironabiochem.com

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Executives

Howard Jarman Verrico

Director, Senior Officer